Relationship of Five Inflammatory Gene Polymorphisms with Morbidity and Mortality in 533 Patients Admitted to an ICU
- 58 Downloads
The aim of this study was to analyze the association of polymorphisms of five candidate genes with the outcome of consecutive patients admitted to a medical ICU.
Materials and Methods
The study population was prospectively recruited. Inclusion criteria were admission to the ICU and written informed consent by the patients or their relatives. A total of 533 patients were recruited. The morbidity was assessed by SAPS II Score. Outcome data of in hospital mortality and length of ICU and hospital stay were obtained. Genotyping for genetic polymorphisms (CRP 1059, IL1B −511, CTGF −477, CCR2 64VI, IL6 −174) were performed by allele-specific fluorogenic oligonucleotide probes (TaqMan analysis).
All of the investigated polymorphisms were not associated with an altered outcome. There was no difference in morbidity and ICU or in-hospital mortality (neither in cross tabs analysis nor in Kaplan Meier or Cox regression analysis including age, gender and diagnosis as covariates) between the different genotypes.
Genotyping of the investigated polymorphism for risk stratification of patients admitted to ICU does not seem to be appropriated.
Key wordsgenetic polymorphism ICU mortality morbidity
This study was supported by the START program of the University Hospital of Aachen and is part of the doctoral thesis of Katharina Vesper.
- 6.Mira, J. P., A. Cariou, F. Grall, C. Delclaux, M. R. Losser, F. Heshmati, C. Cheval, M. Monchi, J. L. Teboul, F. Riche, G. Leleu, L. Arbibe, A. Mignon, M. Delpech, and J. F. Dhainaut. 1999. Association of TNF2, a TNF-alpha promotor polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561–568.PubMedCrossRefGoogle Scholar
- 9.Ohnishi, H., T. Oka, S. Kusachi, T. Nakanishi, K. Takeda, M. Nakahama, M. Doi, T. Murakami, Y. Ninomiya, M. Takigawa, and T. Tsuji. 1998. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell Cardiol. 30:2411–2422.PubMedCrossRefGoogle Scholar
- 12.Ortlepp, J. R., K. Vesper, V. Mevissen, F. Schmitz, U. Janssens, A. Franke, P. Hanrath, C. Weber, K. Zerres, and R. Hoffmann. 2003. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J. Mol. Med. 81:363–367.PubMedCrossRefGoogle Scholar
- 18.Brull, D. J., H. E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G. D. Lowe, and S. E. Humphries. 2001. Interleukin-6 gene 174G>C and 572G>C promoter polymorphism are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 21:1458–1463.PubMedGoogle Scholar
- 19.Ortlepp, J. R., J. Metrikat, K. Vesper, V. Mevissen, F. Schmitz, M. Albrecht, P. Maya-Pelzer, P. Hanrath, K. Zerres, and R. Hoffmann. 2003. The interleukin 6 promotor polymorphism is associated with elevated leukocytes and reduced physical fitness in young healthy smokers. J. Mol. Med. 81:578–584.PubMedCrossRefGoogle Scholar
- 22.Burzetta, F., L. Iacoviello, A. DiCastenuovo, F. Glieca, N. Luciani, R. Zamparelli, R. Schiavello, M. B. Donati, A. Maseri, G. F. Possati, and F. Andreotti. 2001. Relation of the 174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 88:1125–1128.CrossRefGoogle Scholar
- 25.Lee, S. H., C. G. Ihm, S. D. Sohn, T. W. Lee, M. J. Kim, G. Koh, S. J. Oh, J. T. Woo, S. W. Kim, J. W. Kim, Y. S. Kim, B. C. Lee, S. D. Kim, B. S. Cho, H. J. Lee, and J. H. Chung. 2004. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am. J. Nephrol. 24:410–414.PubMedCrossRefGoogle Scholar
- 27.Vozarova, B., J. M. Fernandez-Real, W. C. Knowler, L. Gallart, R. L. Hanson, J. D. Gruber, W. Ricart, J. Vendrell, C. Richart, P. A. Tataranni, and J. K. Wolford. 2003. The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum. Genet. 112:409–413.PubMedGoogle Scholar
- 28.Rundek, T., M. S. Elkind, J. Pittman, B. Boden-Albala, S. Martin, S. E. Humphries, S. H. Juo, and R. L. Sacco. 2002. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33:1420–1423.PubMedCrossRefGoogle Scholar